Kelly Valla, PharmD, BCOP, on Cellular Therapy: New CAR Designs
Kelly Valla, PharmD, BCOP, of Winship Cancer Institute of Emory University, discusses next-generation CAR T cells and what advanced practitioners need to understand about enhanced cytotoxicity and increased persistence of the cells, endogenous anti-tumor immunity, and the immunosuppressive tumor microenvironment.